GlassScriptPhysician profile
Amy Van T Bui
NPI 1013027838
$8,015.32
in general payments reported to CMS, 2019-2025
49 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,820 · 2020: $609 · 2021: $249 · 2022: $655 · 2023: $1,012 · 2024: $1,300 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,639 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,639.42 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $957.77 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $796.71 | 2019-2025 | Repatha, Evenity, Prolia |
| Abbott Laboratories | $778.78 | 2019-2025 | Freestyle Libre 3 |
| Abbvie INC. | $672.53 | 2019-2025 | Synthroid, Ubrelvy |
| Lilly USA, LLC | $641.70 | 2019-2025 | Jardiance, Mounjaro, Trulicity |
| Sanofi-Aventis U.S. LLC | $385.05 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $383.22 | 2019-2025 | Airsupra |
| Dexcom, INC. | $370.18 | 2019-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $262.19 | 2023-2025 | |
| Insulet Corporation | $242.27 | 2019-2025 | Omnipod |
| Radius Health, INC. | $231.75 | 2020-2025 | Tymlos |
| Corcept Therapeutics | $205.07 | 2020-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.13 | 2019-2025 | Jardiance |
| Recordati_rare_diseases_inc. | $144.86 | 2023-2025 | Isturisa, Signifor Lar |
| Janssen Pharmaceuticals, INC | $144.72 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Van Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.